Diseases, Conditions, Syndromes

More drugs show promise in fighting hepatitis C

(HealthDay)β€”An experimental drug duo may cure some cases of the liver disease hepatitis C, without the severe side effects of standard therapy, a new clinical trial suggests.

Inflammatory disorders

Therapy for severe vasculitis shows long-term effectiveness

Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study ...

Oncology & Cancer

Cancer drug shortages hit 83 percent of US oncologists

Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson ...

Oncology & Cancer

New treatment holds promise for resistant lung cancer

A new chemotherapy regimen appears to produce minimal side effects in patients with lung cancer that has not responded to previous therapy, paving the way for additional research to determine if the new regimen also helps ...

page 4 from 12